Skip to content
New

Arkstone Next is here. Expert-in-the-loop AI clinical intelligence for clinics, urgent care and nursing homes.

See what's new Read the announcement
KLAS Emerging Company Spotlight · May 2026

Arkstone OneChoice®, in the words of the customers who use it

KLAS independently interviewed Arkstone customers about how OneChoice turns complex pathogen and resistance data into clear, patient-specific treatment guidance. Here is what they reported.

Cover of the KLAS Emerging Company Spotlight report, Arkstone OneChoice 2026, May 2026.

What KLAS found

89.1*

Overall performance score

vs. 81.1 Best in KLAS average

A*

Likelihood to recommend

A–F grading scale (n=14)

A*

Customer support

A–F grading scale (n=14)

14

Customer organizations interviewed

Verified by KLAS

*Limited data per KLAS Emerging Company Spotlight methodology (n=14). Scores reflect early customer feedback and may change as additional organizations are interviewed.

What customers told KLAS

Built for clarity at the point of care

Interviewed customers described OneChoice as a clear, client-centered solution that simplifies complex lab data into guidance their providers can act on.

User-friendly interface

Customers sign in and start using OneChoice with little to no training. Reports are clean, readable, and designed for use at the point of care.

Clear, actionable reporting

OneChoice distills culture and molecular results into a primary recommendation plus ranked alternatives, so clinicians are not left interpreting complex resistance data on their own.

Responsive support

Customers repeatedly praised the Arkstone team as available, knowledgeable, and quick to resolve issues, describing the partnership as a genuine strength.

“The key strength of OneChoice is that it provides a very clear report that is easy to understand.”
CEO/PresidentKLAS Emerging Company Spotlight, May 2026

About the spotlight

KLAS Research is one of healthcare’s most trusted sources of independent vendor evaluation. Emerging Company Spotlight reports capture verified customer experience with newer solutions, drawn from direct interviews rather than vendor claims.

OneChoice® is Arkstone’s clinical decision-support report for infectious disease. It combines machine learning with expert-in-the-loop clinical oversight to read diagnostic results and return precise, guideline-aligned, patient-specific guidance, supporting the clinician’s decision rather than replacing it.

Hand holding smartphone displaying the OneChoice app.
Next step

See why KLAS spotlighted OneChoice

Book a short walkthrough and see the reports your clinicians would receive.

Book a Demo